VISCONTI, ROBERTA

VISCONTI, ROBERTA  

DIPARTIMENTO DI FARMACIA  

Mostra records
Risultati 1 - 20 di 65 (tempo di esecuzione: 0.032 secondi).
Titolo Tipologia Data di pubblicazione Autore(i) File
Different mutations of the RET gene cause different human tumoral diseases. 1.1 Articolo in rivista 1999 Santoro, M.; Melillo, R. M.; Carlomagno, F.; Visconti, Roberta; DE VITA, Gabriella; Salvatore, Giuliana; Fusco, A.; Vecchio, Giancarlo
Ret-mediated mitogenesis requires Src kinase activity. 1.1 Articolo in rivista 1999 Melillo, R. M.; Barone, M. V.; Lupoli, Gelsy; Cirafici, A. M.; Carlomagno, F.; Visconti, Roberta; Matoskova, B.; DI FIORE, P. P.; Vecchio, Giancarlo; Fusco, A.; Santoro, M.
Overexpression of the HIP gene coding for a heparin/heparan sulfate-binding protein in human thyroid carcinomas. 1.1 Articolo in rivista 1998 Nigris, F. D.; Visconti, R.; Cerutti, J.; Califano, D.; Mineo, A.; Santoro, Massimo; Santelli, G.; Fusco, Alfredo
The highly malignant phenotype of anaplastic thyroid carcinoma cell lines is recessive. 1.1 Articolo in rivista 2000 Martelli, M. L.; Miano, M. G.; Battaglia, C.; Trapasso, F.; Stella, A.; Iuliano, R.; Visconti, R.; Fagin, J. A.; Santoro, Massimo; Fusco, Alfredo
The platelet derived growth factor controls c-myc expression through a JNK- and AP-1-dependent signaling pathway. 1.1 Articolo in rivista 2003 Iavarone, C.; Catania, A.; Marinissen, M. J.; Visconti, R.; Acunzo, M.; Tarantino, C.; Carlomagno, Maria Stella; Bruni, Carmelo Bruno; Gutkind, J. S.; Chiariello, M.
Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival 1.1 Articolo in rivista 2000 De Vita, Gabriella; Melillo, Rosa Marina; Carlomagno, Francesca; Visconti, R; Castellone, Md; Bellacosa, A; Billaud, M; Fusco, Alfredo; Tsichlis, Pn; Santoro, M.
Molecular biology of the MEN2 gene 1.1 Articolo in rivista 1998 Santoro, M; Melillo, Rosa Marina; Carlomagno, Francesca; Visconti, R; De Vita, Gabriella; Salvatore, G; Lupoli, G; Fusco, Alfredo; Vecchio, G.
Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFkappaB p65 protein expression. 1.1 Articolo in rivista 1997 Visconti, R.; Cerutti, J.; Battista, S.; Fedele, M.; Trapasso, F.; Zeki, K.; Miano, M. P.; Nigris, F. D.; Casalino, L.; Curcio, F.; Santoro, Massimo; Fusco, Alfredo
High level expression of the HMGI (Y) gene during embryonic development. 1.1 Articolo in rivista 1996 Chiappetta, G.; Avantaggiato, V.; Visconti, R.; Fedele, M.; Battista, S.; Trapasso, F.; Merciai, B. M.; Fidanza, V.; Giancotti, V.; Santoro, Massimo; Simeone, A.; Fusco, Alfredo
Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease 1.1 Articolo in rivista 1998 Carlomagno, F.; Melillo, Rosa Marina; Visconti, R.; Salvatore, G.; De Vita, Gabriella; Lupoli, G.; Yu, Y. B.; Jing, S. Q.; Vecchio, Giancarlo; Fusco, Alfredo; Santoro, M.
Signalling of the Ret receptor tyrosine kinase through the c-Jun N-terminal Protein Kinases (JNKs): evidence for a divergence of the ERKs and JNKs pathways induced by Ret 1.1 Articolo in rivista 1998 Chiariello, M; Visconti, R; Carlomagno, Francesca; Melillo, Rosa Marina; Bucci, C; De Franciscis, V; Fox, Gm; Jing, S; Coso, Om; Gutkind, Sj; Fusco, Alfredo; Santoro, M.
Akt/PKB promotes survival and hormone-independent proliferation of thyroid cells in the absence of de-differentiated and transforming effects. 1.1 Articolo in rivista 2000 De Vita, Gabriella; Berlingieri, M. T.; Visconti, R.; Castellone, M. D.; Viglietto, G.; Baldassarre, G.; Zannini, Mariastella; Bellacosa, A.; Tsichlis, P. M.; Fusco, A.; Santoro, M.
Only the substitution of methionine 918 with a threonine and not with other residues activates RET transforming potential 1.1 Articolo in rivista 1997 Cirafici, Am; Salvatore, G; De Vita, G; Carlomagno, Francesca; Dathan, Na; Visonti, R; Melillo, Rosa Marina; Fusco, Alfredo; Santoro, M.; Visconti, Roberta
Requirement for proteolysis in spindle assembly checkpoint silencing. 1.1 Articolo in rivista 2010 Visconti, R.; Palazzo, Luca; Grieco, Domenico
New insights on oxidative stress in cancer. 1.1 Articolo in rivista 2009 Visconti, R.; Grieco, Domenico
INCREASED IN-VIVO PHOSPHORILATION OF RET TYROSINE 1062 IS A POTENTIAL PATHOGENETIC MECHANISM OF MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B. 1.1 Articolo in rivista 2001 Salvatore, Domenico; Melillo, Rosa Marina; Monaco, C.; Visconti, R.; Fenzi, G.; Vecchio, G.; Fusco, Alfredo; Santoro, M.
The Expression of the High-mobility Group Hmgi (y) Proteins Correlates With the Malignant Phenotype of Human Thyroid Neoplasias 1.1 Articolo in rivista 1995 Chiappetta, G.; Bandiera, A.; Berlingieri, M. T.; Visconti, R.; Manfioletti, G.; Battista, S.; Martineztello, F. J.; Santoro, Massimo; Giancotti, V.; Fusco, Alfredo
Block of c-myc expression by antisense oligonucleotides inhibits proliferation of human thyroid carcinoma cell lines 1.1 Articolo in rivista 1996 Cerutti, J.; Trapasso, F.; Battaglia, C.; Zhang, L.; Martelli, M. L.; Visconti, R.; Berlingieri, M. T.; Fagin, J. A.; Santoro, Massimo; Fusco, Alfredo
Ret/ptc Oncogene Activation Is An Early Event In Thyroid Carcinogenesis 1.1 Articolo in rivista 1995 Viglietto, G.; Chiappetta, G.; Martineztello, F. J.; Fukunaga, F. H.; Tallini, G.; Rigopoulou, D.; Visconti, R.; Mastro, A.; Santoro, Massimo; Fusco, Alfredo
Retrospective analysis of coagulation factor II receptor (F2R) sequence variation and coronary heart disease in hypertensive patients. 1.1 Articolo in rivista 2007 Gigante, B; Bellis, A; Visconti, R; Marino, M; Morisco, Carmine; Trimarco, Valentina; Galasso, Gennaro; Piscione, Federico; DE LUCA, Nicola; Prince, Ja; de Faire, U; Trimarco, Bruno